부산대학교 도서관

Padrão N; Division of Oncogenomics, The Netherlands Cancer Institute, Amsterdam, The Netherlands.; Oncode Institute, Utrecht, The Netherlands.; Severson TM; Division of Oncogenomics, The Netherlands Cancer Institute, Amsterdam, The Netherlands.; Oncode Institute, Utrecht, The Netherlands.; Gregoricchio S; Division of Oncogenomics, The Netherlands Cancer Institute, Amsterdam, The Netherlands.; Oncode Institute, Utrecht, The Netherlands.; Guijarro A; Department of Internal Medicine and Medical Specialties, University of Genoa, Genoa, Italy.; Lutz C; Oncode Institute, Utrecht, The Netherlands.; Division of Molecular Pathology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.; Taranto D; Oncode Institute, Utrecht, The Netherlands.; Division of Tumor Biology and Immunology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.; Hutten S; Oncode Institute, Utrecht, The Netherlands.; Division of Molecular Pathology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.; Ligorio F; Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.; IFOM ETS, the AIRC Institute of Molecular Oncology, Milan, Italy.; Persia A; Department of Internal Medicine and Medical Specialties, University of Genoa, Genoa, Italy.; IRCCS Ospedale Policlinico San Martino, Genoa, Italy.; Roest M; Division of Oncogenomics, The Netherlands Cancer Institute, Amsterdam, The Netherlands.; Oncode Institute, Utrecht, The Netherlands.; Sanders J; Department of Pathology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.; Song JY; Experimental Animal Pathology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.; Pires-Oliveira S; Department of Pathology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.; Donaldson Collier M; Division of Oncogenomics, The Netherlands Cancer Institute, Amsterdam, The Netherlands.; Oncode Institute, Utrecht, The Netherlands.; Horlings H; Department of Pathology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.; Pisciotta L; Department of Internal Medicine and Medical Specialties, University of Genoa, Genoa, Italy.; IRCCS Ospedale Policlinico San Martino, Genoa, Italy.; de Braud F; Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.; University of Milan, Milan, Italy.; Vernieri C; IFOM ETS, the AIRC Institute of Molecular Oncology, Milan, Italy.; University of Milan, Milan, Italy.; Akkari L; Oncode Institute, Utrecht, The Netherlands.; Division of Tumor Biology and Immunology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.; Jonkers J; Oncode Institute, Utrecht, The Netherlands.; Division of Molecular Pathology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.; Nencioni A; Department of Internal Medicine and Medical Specialties, University of Genoa, Genoa, Italy.; IRCCS Ospedale Policlinico San Martino, Genoa, Italy.; Caffa I; Department of Internal Medicine and Medical Specialties, University of Genoa, Genoa, Italy. irene.caffa@libero.it.; IRCCS Ospedale Policlinico San Martino, Genoa, Italy. irene.caffa@libero.it.; Zwart W; Division of Oncogenomics, The Netherlands Cancer Institute, Amsterdam, The Netherlands. w.zwart@nki.nl.; Oncode Institute, Utrecht, The Netherlands. w.zwart@nki.nl.; Department of Biomedical Engineering, Eindhoven University of Technology, Eindhoven, The Netherlands. w.zwart@nki.nl.

Publisher: Nature Publishing Group Country of Publication: England NLM ID: 0410462 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1476-4687 (Electronic) Linking ISSN: 00280836 NLM ISO Abbreviation: Nature Subsets: MEDLINE

Gregoricchio S; Division of Oncogenomics, Oncode Institute, The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands. s.gregoricchio@nki.nl.; Kojic A; Division of Oncogenomics, Oncode Institute, The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands.; Hoogstraat M; Division of Oncogenomics, Oncode Institute, The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands.; Division of Molecular Carcinogenesis, Oncode Institute, The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands.; Schuurman K; Division of Oncogenomics, Oncode Institute, The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands.; Stelloo S; Department of Molecular Biology, Faculty of Science, Radboud Institute for Molecular Life Sciences, Oncode Institute, Radboud University Nijmegen, Geert Grooteplein Zuid 28, 6525GA, Nijmegen, The Netherlands.; Severson TM; Division of Oncogenomics, Oncode Institute, The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands.; Division of Molecular Carcinogenesis, Oncode Institute, The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands.; O'Mara TA; Cancer Research Program, QIMR Berghofer Medical Research Institute, Locked Bag 2000, Brisbane, QLD, 4029, Australia.; Droog M; Division of Oncogenomics, Oncode Institute, The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands.; Singh AA; Division of Oncogenomics, Oncode Institute, The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands.; Glubb DM; Cancer Research Program, QIMR Berghofer Medical Research Institute, Locked Bag 2000, Brisbane, QLD, 4029, Australia.; Wessels LFA; Division of Molecular Carcinogenesis, Oncode Institute, The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands.; Vermeulen M; Department of Molecular Biology, Faculty of Science, Radboud Institute for Molecular Life Sciences, Oncode Institute, Radboud University Nijmegen, Geert Grooteplein Zuid 28, 6525GA, Nijmegen, The Netherlands.; Division of Molecular Genetics, Oncode Institute, The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands.; van Leeuwen FE; Department of Epidemiology, The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands.; Zwart W; Division of Oncogenomics, Oncode Institute, The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands. w.zwart@nki.nl.; Laboratory of Chemical Biology and Institute for Complex Molecular Systems, Department of Biomedical Engineering, Eindhoven University of Technology, P.O. Box 513, 5600 MB, Eindhoven, The Netherlands. w.zwart@nki.nl.

Publisher: BioMed Central Ltd Country of Publication: England NLM ID: 100960660 Publication Model: Electronic Cited Medium: Internet ISSN: 1474-760X (Electronic) Linking ISSN: 14747596 NLM ISO Abbreviation: Genome Biol Subsets: MEDLINE

Mayayo-Peralta, Isabel; Gregoricchio, Sebastian; Schuurman, Karianne; Yavuz, Selçuk; Zaalberg, Anniek; Kojic, Aleksandar; Abbott, Nina; Geverts, Bart; Beerthuijzen, Suzanne; Siefert, Joseph; Severson, Tesa M; van Baalen, Martijn; Hoekman, Liesbeth; Lieftink, Cor; Altelaar, Maarten; Beijersbergen, Roderick L; Houtsmuller, Adriaan B; Prekovic, Stefan; Zwart, Wilbert

Nucleic Acids Research; 10/13/2023, Vol. 51 Issue 18, p9576-9593, 18p

Friskes, Anoek; Koob, Lisa; Krenning, Lenno; Severson, Tesa M; Koeleman, Emma S; Vergara, Xabier; Schubert, Michael; van den Berg, Jeroen; Evers, Bastiaan; Manjón, Anna G; Joosten, Stacey; Kim, Yongsoo; Zwart, Wilbert; Medema, René H

Nucleic Acids Research; 9/23/2022, Vol. 50 Issue 17, p9930-9947, 18p

Padrão N; Division of Oncogenomics, Oncode Institute, The Netherlands Cancer Institute, Amsterdam 1066 CX, The Netherlands.; Gregoricchio S; Division of Oncogenomics, Oncode Institute, The Netherlands Cancer Institute, Amsterdam 1066 CX, The Netherlands.; Eickhoff N; Division of Oncogenomics, Oncode Institute, The Netherlands Cancer Institute, Amsterdam 1066 CX, The Netherlands.; Dong J; Division of Oncogenomics, Oncode Institute, The Netherlands Cancer Institute, Amsterdam 1066 CX, The Netherlands.; Luzietti L; School of Pharmacy and Biomolecular Sciences, Royal College of Surgeons in Ireland, University of Medicine and Health Sciences, Dublin D02 YN77, Ireland.; Bossi D; Institute of Oncology Research, Bellinzona 6500, Switzerland.; Faculty of Biomedical Sciences, Università della Svizzera Italiana, Lugano 6962, Switzerland.; Severson TM; Division of Oncogenomics, Oncode Institute, The Netherlands Cancer Institute, Amsterdam 1066 CX, The Netherlands.; Siefert J; Division of Oncogenomics, Oncode Institute, The Netherlands Cancer Institute, Amsterdam 1066 CX, The Netherlands.; Calcinotto A; Institute of Oncology Research, Bellinzona 6500, Switzerland.; Faculty of Biomedical Sciences, Università della Svizzera Italiana, Lugano 6962, Switzerland.; Buluwela L; Department of Surgery and Cancer, Imperial College London, London SW7 2BX, United Kingdom.; Donaldson Collier M; Division of Oncogenomics, Oncode Institute, The Netherlands Cancer Institute, Amsterdam 1066 CX, The Netherlands.; Ali S; Department of Surgery and Cancer, Imperial College London, London SW7 2BX, United Kingdom.; Young L; Endocrine Oncology Research Group, Department of Surgery, Royal College of Surgeons in Ireland, University of Medicine and Health Sciences, Dublin D02 YN77, Ireland.; Beaumont Royal College of Surgeons in Ireland Cancer Centre, Beaumont Hospital, Dublin D09 V2N0, Ireland.; Theurillat JP; Institute of Oncology Research, Bellinzona 6500, Switzerland.; Faculty of Biomedical Sciences, Università della Svizzera Italiana, Lugano 6962, Switzerland.; Varešlija D; School of Pharmacy and Biomolecular Sciences, Royal College of Surgeons in Ireland, University of Medicine and Health Sciences, Dublin D02 YN77, Ireland.; Beaumont Royal College of Surgeons in Ireland Cancer Centre, Beaumont Hospital, Dublin D09 V2N0, Ireland.; Zwart W; Division of Oncogenomics, Oncode Institute, The Netherlands Cancer Institute, Amsterdam 1066 CX, The Netherlands.

Publisher: National Academy of Sciences Country of Publication: United States NLM ID: 7505876 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1091-6490 (Electronic) Linking ISSN: 00278424 NLM ISO Abbreviation: Proc Natl Acad Sci U S A Subsets: MEDLINE

Severson TM; Division of Oncogenomics, The Netherlands Cancer Institute, 1066 CX Amsterdam, the Netherlands; Cancer Genomics Netherlands, Oncode Institute, 3584 CG Utrecht, the Netherlands; Division of Molecular Carcinogenesis, The Netherlands Cancer Institute, 1066 CX Amsterdam, the Netherlands.; Minnee E; Division of Oncogenomics, The Netherlands Cancer Institute, 1066 CX Amsterdam, the Netherlands; Cancer Genomics Netherlands, Oncode Institute, 3584 CG Utrecht, the Netherlands.; Zhu Y; Division of Oncogenomics, The Netherlands Cancer Institute, 1066 CX Amsterdam, the Netherlands; Cancer Genomics Netherlands, Oncode Institute, 3584 CG Utrecht, the Netherlands.; Schuurman K; Division of Oncogenomics, The Netherlands Cancer Institute, 1066 CX Amsterdam, the Netherlands.; Nguyen HM; Department of Urology, University of Washington, Seattle, WA 98195, USA.; Brown LG; Department of Urology, University of Washington, Seattle, WA 98195, USA.; Hakkola S; Prostate Cancer Research Center, Faculty of Medicine and Health Technology, Tampere University and Tays Cancer Centre, 33100 Tampere, Finland.; Menezes R; Biostatistics Centre & Department of Psychosocial Research and Epidemiology, the Netherlands Cancer Institute, 1066 CX Amsterdam, the Netherlands.; Gregoricchio S; Division of Oncogenomics, The Netherlands Cancer Institute, 1066 CX Amsterdam, the Netherlands; Cancer Genomics Netherlands, Oncode Institute, 3584 CG Utrecht, the Netherlands.; Kim Y; Division of Oncogenomics, The Netherlands Cancer Institute, 1066 CX Amsterdam, the Netherlands.; Kneppers J; Division of Oncogenomics, The Netherlands Cancer Institute, 1066 CX Amsterdam, the Netherlands; Cancer Genomics Netherlands, Oncode Institute, 3584 CG Utrecht, the Netherlands.; Linder S; Division of Oncogenomics, The Netherlands Cancer Institute, 1066 CX Amsterdam, the Netherlands; Cancer Genomics Netherlands, Oncode Institute, 3584 CG Utrecht, the Netherlands.; Stelloo S; Division of Oncogenomics, The Netherlands Cancer Institute, 1066 CX Amsterdam, the Netherlands; Cancer Genomics Netherlands, Oncode Institute, 3584 CG Utrecht, the Netherlands.; Lieftink C; Division of Molecular Carcinogenesis and NKI Robotics and Screening Center, The Netherlands Cancer Institute, 1066 CX Amsterdam, the Netherlands.; van der Heijden MS; Division of Molecular Carcinogenesis, The Netherlands Cancer Institute, 1066 CX Amsterdam, the Netherlands; Division of Medical Oncology, The Netherlands Cancer Institute, 1066 CX Amsterdam, the Netherlands.; Nykter M; Prostate Cancer Research Center, Faculty of Medicine and Health Technology, Tampere University and Tays Cancer Centre, 33100 Tampere, Finland.; van der Noort V; Department of Biometrics, The Netherlands Cancer Institute, 1066 CX Amsterdam, the Netherlands.; Sanders J; Department of Pathology, The Netherlands Cancer Institute, 1066 CX Amsterdam, the Netherlands.; Morris B; Division of Molecular Carcinogenesis and NKI Robotics and Screening Center, The Netherlands Cancer Institute, 1066 CX Amsterdam, the Netherlands.; Jenster G; Department of Urology, Erasmus MC, 3015 GD Rotterdam, the Netherlands.; van Leenders GJ; Department of Pathology, Erasmus MC Cancer Institute, 3015 CP Rotterdam, the Netherlands.; Pomerantz M; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA 02215, USA.; Freedman ML; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA 02215, USA; The Eli and Edythe L. Broad Institute, Cambridge, MA 02142, USA.; Beijersbergen RL; Division of Molecular Carcinogenesis and NKI Robotics and Screening Center, The Netherlands Cancer Institute, 1066 CX Amsterdam, the Netherlands.; Urbanucci A; Prostate Cancer Research Center, Faculty of Medicine and Health Technology, Tampere University and Tays Cancer Centre, 33100 Tampere, Finland; Department of Tumor Biology, Institute for Cancer Research, Oslo University Hospital, 0424 Oslo, Norway.; Wessels L; Cancer Genomics Netherlands, Oncode Institute, 3584 CG Utrecht, the Netherlands; Division of Molecular Carcinogenesis, The Netherlands Cancer Institute, 1066 CX Amsterdam, the Netherlands; Department of EEMCS, Delft University of Technology, 2628 CM Delft, the Netherlands.; Nelson PS; Divisions of Human Biology and Clinical Research, Fred Hutchinson Cancer Center, Seattle, WA 98109, USA; Department of Medicine, Division of Medical Oncology, University of Washington, Seattle, WA 98195, USA.; Corey E; Department of Urology, University of Washington, Seattle, WA 98195, USA.; Prekovic S; Division of Oncogenomics, The Netherlands Cancer Institute, 1066 CX Amsterdam, the Netherlands; Cancer Genomics Netherlands, Oncode Institute, 3584 CG Utrecht, the Netherlands.; Zwart W; Division of Oncogenomics, The Netherlands Cancer Institute, 1066 CX Amsterdam, the Netherlands; Cancer Genomics Netherlands, Oncode Institute, 3584 CG Utrecht, the Netherlands; Laboratory of Chemical Biology and Institute for Complex Molecular Systems, Department of Biomedical Engineering, Eindhoven University of Technology, 5600 MB Eindhoven, the Netherlands. Electronic address: w.zwart@nki.nl.; Bergman AM; Division of Oncogenomics, The Netherlands Cancer Institute, 1066 CX Amsterdam, the Netherlands; Division of Medical Oncology, The Netherlands Cancer Institute, 1066 CX Amsterdam, the Netherlands; Department of Medical Oncology, Amsterdam UMC, University of Amsterdam, 1105 AZ Amsterdam, the Netherlands. Electronic address: a.bergman@nki.nl.

Publisher: Cell Press Country of Publication: United States NLM ID: 101766894 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2666-3791 (Electronic) Linking ISSN: 26663791 NLM ISO Abbreviation: Cell Rep Med Subsets: MEDLINE

Michaut, Magali; Chin, Suet-Feung; Majewski, Ian; Severson, Tesa M; Bismeijer, Tycho; de Koning, Leanne; Peeters, Justine K; Schouten, Philip C; Rueda, Oscar M; Bosma, Astrid J; Tarrant, Finbarr; Fan, Yue; He, Beilei; Xue, Zheng; Mittempergher, Lorenza; Kluin, Roelof J C; Heijmans, Jeroen; Snel, Mireille; Pereira, Bernard; Schlicker, Andreas; Provenzano, Elena; Ali, Hamid Raza; Gaber, Alexander; O'Hurley, Gillian; Lehn, Sophie; Muris, Jettie J F; Wesseling, Jelle; Kay, Elaine; Sammut, Stephen John; Bardwell, Helen A; Barbet, Aurélie S; Bard, Floriane; Lecerf, Caroline; O'Connor, Darran P; Vis, Daniël J; Benes, Cyril H; McDermott, Ultan; Garnett, Mathew J; Simon, Iris M; Jirström, Karin; Dubois, Thierry; Linn, Sabine C; Gallagher, William M; Wessels, Lodewyk F A; Caldas, Carlos; Bernards, Rene

Scientific Reports. 6

Kneppers J; Division of Oncogenomics, Oncode Institute, Netherlands Cancer Institute, Amsterdam, The Netherlands.; Severson TM; Division of Oncogenomics, Oncode Institute, Netherlands Cancer Institute, Amsterdam, The Netherlands.; Division of Molecular Carcinogenesis, Oncode Institute, Netherlands Cancer Institute, Amsterdam, the Netherlands.; Siefert JC; Division of Oncogenomics, Oncode Institute, Netherlands Cancer Institute, Amsterdam, The Netherlands.; Division of Molecular Carcinogenesis, Oncode Institute, Netherlands Cancer Institute, Amsterdam, the Netherlands.; Schol P; Division of Oncogenomics, Oncode Institute, Netherlands Cancer Institute, Amsterdam, The Netherlands.; Joosten SEP; Division of Oncogenomics, Oncode Institute, Netherlands Cancer Institute, Amsterdam, The Netherlands.; Yu IPL; Vancouver Prostate Centre, Department of Urologic Science, University of British Columbia, Vancouver, Canada.; Huang CF; Vancouver Prostate Centre, Department of Urologic Science, University of British Columbia, Vancouver, Canada.; Morova T; Vancouver Prostate Centre, Department of Urologic Science, University of British Columbia, Vancouver, Canada.; Altıntaş UB; School of Medicine, Koç University, Istanbul, Turkey.; Giambartolomei C; Central RNA Lab, Istituto Italiano di Tecnologia, Genova, Italy.; Department of Pathology and Laboratory Medicine, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, USA.; Seo JH; Department of Pathology and Laboratory Medicine, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, USA.; The Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, USA.; Baca SC; The Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, USA.; Carneiro I; Department of Pathology, Cancer Biology and Epigenetics Group, Portuguese Oncology Institute of Porto and Porto Comprehensive Cancer Center, Porto, Portugal.; Emberly E; Department of Physics, Simon Fraser University, Burnaby, Canada.; Pasaniuc B; Department of Pathology and Laboratory Medicine, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, USA.; Jerónimo C; Department of Pathology, Cancer Biology and Epigenetics Group, Portuguese Oncology Institute of Porto and Porto Comprehensive Cancer Center, Porto, Portugal.; Henrique R; Department of Pathology, Cancer Biology and Epigenetics Group, Portuguese Oncology Institute of Porto and Porto Comprehensive Cancer Center, Porto, Portugal.; Freedman ML; The Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, USA.; Department of Medical Oncology, The Center for Functional Cancer Epigenetics, Dana Farber Cancer Institute, Boston, USA.; Wessels LFA; Division of Molecular Carcinogenesis, Oncode Institute, Netherlands Cancer Institute, Amsterdam, the Netherlands.; Lack NA; Vancouver Prostate Centre, Department of Urologic Science, University of British Columbia, Vancouver, Canada.; School of Medicine, Koç University, Istanbul, Turkey.; Koç University Research Centre for Translational Medicine (KUTTAM), Koç University, Istanbul, Turkey.; Bergman AM; Division of Oncogenomics, Oncode Institute, Netherlands Cancer Institute, Amsterdam, The Netherlands. a.bergman@nki.nl.; Division of Medical Oncology, Netherlands Cancer Institute, Amsterdam, the Netherlands. a.bergman@nki.nl.; Zwart W; Division of Oncogenomics, Oncode Institute, Netherlands Cancer Institute, Amsterdam, The Netherlands. w.zwart@nki.nl.; Laboratory of Chemical Biology and Institute for Complex Molecular Systems, Department of Biomedical Engineering, Eindhoven University of Technology, Eindhoven, The Netherlands. w.zwart@nki.nl.

Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101528555 Publication Model: Electronic Cited Medium: Internet ISSN: 2041-1723 (Electronic) Linking ISSN: 20411723 NLM ISO Abbreviation: Nat Commun Subsets: MEDLINE

Che, Meixia; Chaturvedi, Aashi; Munro, Sarah A; Pitzen, Samuel P; Ling, Alex; Zhang, Weijie; Mentzer, Josh; Ku, Sheng-Yu; Puca, Loredana; Zhu, Yanyun; Bergman, Andries M; Severson, Tesa M; Forster, Colleen; Liu, Yuzhen; Hildebrand, Jacob; Daniel, Mark; Wang, Ting-You; Selth, Luke A; Hickey, Theresa; Zoubeidi, Amina; Gleave, Martin; Bareja, Rohan; Sboner, Andrea; Tilley, Wayne; Carroll, Jason S; Tan, Winston; Kohli, Manish; Yang, Rendong; Hsieh, Andrew C; Murugan, Paari; Zwart, Wilbert; Beltran, Himisha; Huang, R Stephanie; Dehm, Scott M

Nat Commun
Nature Communications, Vol 12, Iss 1, Pp 1-15 (2021)

Severson TM; Division of Oncogenomics, Oncode Institute, Netherlands Cancer Institute, Amsterdam, the Netherlands.; Division of Molecular Oncogenesis, Oncode Institute, Netherlands Cancer Institute, Amsterdam, the Netherlands.; Zhu Y; Division of Oncogenomics, Oncode Institute, Netherlands Cancer Institute, Amsterdam, the Netherlands.; De Marzo AM; Sidney Kimmel Comprehensive Cancer Center, Department of Pathology, Brady Urological Institute, Johns Hopkins School of Medicine, Baltimore, MD, USA.; Jones T; Department of Pathology, Johns Hopkins School of Medicine, Baltimore, MD, USA.; Simons JW; Prostate Cancer Foundation, Santa Monica, CA, USA.; Nelson WG; Sidney Kimmel Comprehensive Cancer Center, Department of Pathology, Brady Urological Institute, Johns Hopkins School of Medicine, Baltimore, MD, USA.; Yegnasubramanian S; Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins School of Medicine, Baltimore, MD, USA.; Freedman ML; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.; The Eli and Edythe L. Broad Institute, Cambridge, MA, USA.; Wessels L; Division of Molecular Oncogenesis, Oncode Institute, Netherlands Cancer Institute, Amsterdam, the Netherlands.; Bergman AM; Division of Oncogenomics, Oncode Institute, Netherlands Cancer Institute, Amsterdam, the Netherlands.; Department of Medical Oncology, Netherlands Cancer Institute, Amsterdam, the Netherlands.; Haffner MC; Divisions of Human Biology and Clinical Research, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.; Department of Pathology, University of Washington, Seattle, WA, USA.; Department of Pathology, Johns Hopkins School of Medicine, Baltimore, MD, USA.; Zwart W; Division of Oncogenomics, Oncode Institute, Netherlands Cancer Institute, Amsterdam, the Netherlands.; Laboratory of Chemical Biology and Institute for Complex Molecular Systems, Department of Biomedical Engineering, Eindhoven University of Technology, Eindhoven, the Netherlands.

Publisher: John Wiley & Sons, Inc Country of Publication: United States NLM ID: 101308230 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1878-0261 (Electronic) Linking ISSN: 15747891 NLM ISO Abbreviation: Mol Oncol Subsets: MEDLINE

Shafi AA; Department of Cancer Biology, Thomas Jefferson University, Philadelphia, PA, 19107, USA.; McNair CM; Department of Cancer Biology, Thomas Jefferson University, Philadelphia, PA, 19107, USA.; Sidney Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, PA, 19107, USA.; McCann JJ; Department of Cancer Biology, Thomas Jefferson University, Philadelphia, PA, 19107, USA.; Duke University, Durham, NC, 27708, USA.; Alshalalfa M; Department of Radiation Oncology, University of California at San Francisco, San Francisco, CA, 94115, USA.; Shostak A; Biochemistry Center, University of Heidelberg, Heidelberg, Germany.; Severson TM; Division of Oncogenomics, Oncode Institute, The Netherlands Cancer Institute, Amsterdam, The Netherlands.; Zhu Y; Division of Oncogenomics, Oncode Institute, The Netherlands Cancer Institute, Amsterdam, The Netherlands.; Bergman A; Division of Oncogenomics, Oncode Institute, The Netherlands Cancer Institute, Amsterdam, The Netherlands.; Gordon N; Department of Cancer Biology, Thomas Jefferson University, Philadelphia, PA, 19107, USA.; Mandigo AC; Department of Cancer Biology, Thomas Jefferson University, Philadelphia, PA, 19107, USA.; Chand SN; Department of Cancer Biology, Thomas Jefferson University, Philadelphia, PA, 19107, USA.; Gallagher P; Department of Cancer Biology, Thomas Jefferson University, Philadelphia, PA, 19107, USA.; Dylgjeri E; Department of Cancer Biology, Thomas Jefferson University, Philadelphia, PA, 19107, USA.; Laufer TS; Department of Cancer Biology, Thomas Jefferson University, Philadelphia, PA, 19107, USA.; Vasilevskaya IA; Department of Cancer Biology, Thomas Jefferson University, Philadelphia, PA, 19107, USA.; Schiewer MJ; Department of Cancer Biology, Thomas Jefferson University, Philadelphia, PA, 19107, USA.; Department of Urology, Medical Oncology and Radiation Oncology, Thomas Jefferson University, Philadelphia, PA, USA.; Brunner M; Biochemistry Center, University of Heidelberg, Heidelberg, Germany.; Feng FY; Department of Radiation Oncology, University of California at San Francisco, San Francisco, CA, 94115, USA.; Zwart W; Division of Oncogenomics, Oncode Institute, The Netherlands Cancer Institute, Amsterdam, The Netherlands.; Knudsen KE; Department of Cancer Biology, Thomas Jefferson University, Philadelphia, PA, 19107, USA. karen.knudsen@jefferson.edu.; Sidney Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, PA, 19107, USA. karen.knudsen@jefferson.edu.; Department of Urology, Medical Oncology and Radiation Oncology, Thomas Jefferson University, Philadelphia, PA, USA. karen.knudsen@jefferson.edu.

Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101528555 Publication Model: Electronic Cited Medium: Internet ISSN: 2041-1723 (Electronic) Linking ISSN: 20411723 NLM ISO Abbreviation: Nat Commun Subsets: MEDLINE

Linder S; Division of Oncogenomics, Oncode Institute, The Netherlands Cancer Institute, Amsterdam, The Netherlands.; Severson TM; Division of Oncogenomics, Oncode Institute, The Netherlands Cancer Institute, Amsterdam, The Netherlands; Division of Molecular Carcinogenesis, Oncode Institute, The Netherlands Cancer Institute, Amsterdam, The Netherlands.; van der Mijn KJC; Division of Medical Oncology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.; Nevedomskaya E; Division of Oncogenomics, Oncode Institute, The Netherlands Cancer Institute, Amsterdam, The Netherlands; Division of Molecular Carcinogenesis, Oncode Institute, The Netherlands Cancer Institute, Amsterdam, The Netherlands.; Siefert JC; Division of Oncogenomics, Oncode Institute, The Netherlands Cancer Institute, Amsterdam, The Netherlands; Division of Molecular Carcinogenesis, Oncode Institute, The Netherlands Cancer Institute, Amsterdam, The Netherlands.; Stelloo S; Division of Oncogenomics, Oncode Institute, The Netherlands Cancer Institute, Amsterdam, The Netherlands.; Pomerantz MM; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.; Freedman ML; The Eli and Edythe L. Broad Institute, Cambridge, MA, USA; Division of Urology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.; van der Poel H; Division of Urology, The Netherlands Cancer Institute, Amsterdam, The Netherlands; Department of Urology, Amsterdam University Medical Centers, Amsterdam, The Netherlands.; Jerónimo C; Cancer Biology and Epigenetics Group, Research Center of the Portuguese Oncology Institute of Porto, Porto, Portugal; Department of Pathology, Portuguese Oncology Institute of Porto, Porto, Portugal; Department of Pathology and Molecular Immunology, School of Medicine and Biomedical Sciences, University of Porto, Porto, Portugal.; Henrique R; Cancer Biology and Epigenetics Group, Research Center of the Portuguese Oncology Institute of Porto, Porto, Portugal; Department of Pathology, Portuguese Oncology Institute of Porto, Porto, Portugal; Department of Pathology and Molecular Immunology, School of Medicine and Biomedical Sciences, University of Porto, Porto, Portugal.; Bergman AM; Division of Medical Oncology, The Netherlands Cancer Institute, Amsterdam, The Netherlands; Division of Oncogenomics, The Netherlands Cancer Institute, Amsterdam, The Netherlands. Electronic address: a.bergman@nki.nl.; Zwart W; Division of Oncogenomics, Oncode Institute, The Netherlands Cancer Institute, Amsterdam, The Netherlands; Laboratory of Chemical Biology and Institute for Complex Molecular Systems, Department of Biomedical Engineering, Eindhoven University of Technology, Eindhoven, The Netherlands. Electronic address: w.zwart@nki.nl.

Publisher: Elsevier Science Country of Publication: Switzerland NLM ID: 7512719 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1873-7560 (Electronic) Linking ISSN: 03022838 NLM ISO Abbreviation: Eur Urol Subsets: MEDLINE

Severson, Tesa M; Nevedomskaya, Ekaterina; Peeters, Justine; Kuilman, Thomas; Krijgsman, Oscar; van Rossum, Annelot; Droog, Marjolein; Kim, Yongsoo; Koornstra, Rutger; Beumer, Inès; Glas, Annuska M; Peeper, Daniel; Wesseling, Jelle; Simon, Iris M; Wessels, Lodewyk; Linn, Sabine C; Zwart, Wilbert

Oncotarget
Severson, T M, Nevedomskaya, E, Peeters, J, Kuilman, T, Krijgsman, O, van Rossum, A, Droog, M, Kim, Y, Koornstra, R, Beumer, I, Glas, A M, Peeper, D, Wesseling, J, Simon, I M, Wessels, L, Linn, S C & Zwart, W 2016, 'Neoadjuvant tamoxifen synchronizes ERα binding and gene expression profiles related to outcome and proliferation', Oncotarget, vol. 7, no. 23, pp. 33901-18. https://doi.org/10.18632/oncotarget.8983

Millar R; Institute of Cancer Sciences, University of Glasgow, Glasgow, UK.; Cancer Research UK Beatson Institute, Glasgow, UK.; Kilbey A; Institute of Cancer Sciences, University of Glasgow, Glasgow, UK.; Cancer Research UK Beatson Institute, Glasgow, UK.; Remak SJ; Institute of Cancer Sciences, University of Glasgow, Glasgow, UK.; Cancer Research UK Beatson Institute, Glasgow, UK.; Severson TM; Division of Oncogenesis, Netherlands Cancer Institute, Amsterdam, The Netherlands.; Dhayade S; Cancer Research UK Beatson Institute, Glasgow, UK.; Sandilands E; Institute of Cancer Sciences, University of Glasgow, Glasgow, UK.; Cancer Research UK Beatson Institute, Glasgow, UK.; Foster K; Institute of Cancer Sciences, University of Glasgow, Glasgow, UK.; Cancer Research UK Beatson Institute, Glasgow, UK.; Bryant DM; Institute of Cancer Sciences, University of Glasgow, Glasgow, UK.; Cancer Research UK Beatson Institute, Glasgow, UK.; Blyth K; Institute of Cancer Sciences, University of Glasgow, Glasgow, UK.; Cancer Research UK Beatson Institute, Glasgow, UK.; Coffelt SB; Institute of Cancer Sciences, University of Glasgow, Glasgow, UK.; Cancer Research UK Beatson Institute, Glasgow, UK.

Publisher: John Wiley & Sons, Inc Country of Publication: United States NLM ID: 101308230 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1878-0261 (Electronic) Linking ISSN: 15747891 NLM ISO Abbreviation: Mol Oncol Subsets: MEDLINE

Severson, Tesa M; Peeters, Justine; Majewski, Ian; Michaut, Magali; Bosma, Astrid; Schouten, Philip C; Chin, Suet-Feung; Pereira, Bernard; Goldgraben, Mae A; Bismeijer, Tycho; Kluin, Roelof JC; Muris, Jettie JF; Jirström, Karin; Kerkhoven, Ron M; Wessels, Lodewyk; Caldas, Carlos; Bernards, René; Simon, Iris M; Linn, Sabine

Mol Oncol
Molecular Oncology

Schouten, Philip C; Grigoriadis, Anita; Kuilman, Thomas; Mirza, Hasan; Watkins, Johnathan A; Cooke, Saskia A; Van Dyk, Ewald; Severson, Tesa M; Rueda, Oscar M; Hoogstraat, Marlous; Verhagen, Caroline VM; Natrajan, Rachael; Chin, Suet-Feung; Lips, Esther H; Kruizinga, Janneke; Velds, Arno; Nieuwland, Marja; Kerkhoven, Ron M; Krijgsman, Oscar; Vens, Conchita; Peeper, Daniel; Nederlof, Petra M; Caldas, Carlos; Tutt, Andrew N; Wessels, Lodewyk F; Linn, Sabine C

Mol Oncol
Molecular Oncology, Vol 9, Iss 7, Pp 1274-1286 (2015)
Molecular Oncology, 9, 7, pp. 1274-86
Schouten, P C, Grigoriadis, A, Kuilman, T, Mirza, H, Watkins, J A, Cooke, S A, van Dyk, E, Severson, T M, Rueda, O M, Hoogstraat, M, Verhagen, C V M, Natrajan, R, Chin, S-F, Lips, E H, Kruizinga, J, Velds, A, Nieuwland, M, Kerkhoven, R M, Krijgsman, O, Vens, C, Peeper, D, Nederlof, P M, Caldas, C, Tutt, A N, Wessels, L F & Linn, S C 2015, ' Robust BRCA1-like classification of copy number profiles of samples repeated across different datasets and platforms ', Molecular Oncology, vol. 9, no. 7, pp. 1274-86 . https://doi.org/10.1016/j.molonc.2015.03.002
Molecular Oncology

Zhou S; Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada.; Department of Medical Biophysics, University of Toronto, Toronto, ON, Canada.; Hawley JR; Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada.; Department of Medical Biophysics, University of Toronto, Toronto, ON, Canada.; Soares F; Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada.; Grillo G; Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada.; Teng M; Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada.; Department of Medical Biophysics, University of Toronto, Toronto, ON, Canada.; Madani Tonekaboni SA; Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada.; Department of Medical Biophysics, University of Toronto, Toronto, ON, Canada.; Hua JT; Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada.; Department of Medical Biophysics, University of Toronto, Toronto, ON, Canada.; Kron KJ; Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada.; Mazrooei P; Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada.; Department of Medical Biophysics, University of Toronto, Toronto, ON, Canada.; Ahmed M; Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada.; Arlidge C; Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada.; Yun HY; Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada.; Livingstone J; Ontario Institute for Cancer Research, Toronto, ON, Canada.; Huang V; Ontario Institute for Cancer Research, Toronto, ON, Canada.; Yamaguchi TN; Ontario Institute for Cancer Research, Toronto, ON, Canada.; Espiritu SMG; Ontario Institute for Cancer Research, Toronto, ON, Canada.; Zhu Y; Division of Oncogenomics, Oncode Institute, the Netherlands Cancer Institute, Amsterdam, The Netherlands.; Severson TM; Division of Oncogenomics, Oncode Institute, the Netherlands Cancer Institute, Amsterdam, The Netherlands.; Murison A; Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada.; Cameron S; Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada.; Zwart W; Division of Oncogenomics, Oncode Institute, the Netherlands Cancer Institute, Amsterdam, The Netherlands.; Laboratory of Chemical Biology and Institute for Complex Molecular Systems, Department of Biomedical Engineering, Eindhoven University of Technology, Eindhoven, The Netherlands.; van der Kwast T; Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON, Canada.; Pugh TJ; Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada.; Department of Medical Biophysics, University of Toronto, Toronto, ON, Canada.; Ontario Institute for Cancer Research, Toronto, ON, Canada.; Fraser M; Ontario Institute for Cancer Research, Toronto, ON, Canada.; Boutros PC; Department of Medical Biophysics, University of Toronto, Toronto, ON, Canada.; Ontario Institute for Cancer Research, Toronto, ON, Canada.; Department of Pharmacology and Toxicology, University of Toronto, Toronto, CA, Canada.; Department of Human Genetics, University of California, Los Angeles, CA, USA.; Department of Urology, University of California, Los Angeles, CA, USA.; Institute for Precision Health, University of California, Los Angeles, CA, USA.; Jonsson Comprehensive Cancer Center, University of California, Los Angeles, CA, USA.; Bristow RG; Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada.; Department of Medical Biophysics, University of Toronto, Toronto, ON, Canada.; Department of Radiation Oncology, University of Toronto, Toronto, ON, Canada.; CRUK Manchester Institute and Manchester Cancer Research Centre, Manchester, UK.; Division of Cancer Sciences, Faculty of Biology, Health and Medicine, University of Manchester, Manchester, UK.; The Christie NHS Foundation Trust, Manchester, UK.; He HH; Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada.; Department of Medical Biophysics, University of Toronto, Toronto, ON, Canada.; Lupien M; Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada. mlupien@uhnresearch.ca.; Department of Medical Biophysics, University of Toronto, Toronto, ON, Canada. mlupien@uhnresearch.ca.; Ontario Institute for Cancer Research, Toronto, ON, Canada. mlupien@uhnresearch.ca.

Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101528555 Publication Model: Electronic Cited Medium: Internet ISSN: 2041-1723 (Electronic) Linking ISSN: 20411723 NLM ISO Abbreviation: Nat Commun Subsets: MEDLINE

Ahrends T; Division of Tumor Biology and Immunology, The Netherlands Cancer Institute-Antoni van Leeuwenhoek, 1066 CX, Amsterdam, The Netherlands.; Laboratory of Mucosal Immunology, The Rockefeller University, New York, NY, USA.; Busselaar J; Division of Tumor Biology and Immunology, The Netherlands Cancer Institute-Antoni van Leeuwenhoek, 1066 CX, Amsterdam, The Netherlands.; Department of Immunohematology and Blood Transfusion, Leiden University Medical Center, Leiden, The Netherlands.; Severson TM; Division of Molecular Carcinogenesis, Oncode Institute, The Netherlands Cancer Institute-Antoni van Leeuwenhoek, 1066 CX, Amsterdam, The Netherlands.; Bąbała N; Division of Tumor Biology and Immunology, The Netherlands Cancer Institute-Antoni van Leeuwenhoek, 1066 CX, Amsterdam, The Netherlands.; de Vries E; Division of Tumor Biology and Immunology, The Netherlands Cancer Institute-Antoni van Leeuwenhoek, 1066 CX, Amsterdam, The Netherlands.; Department of Immunohematology and Blood Transfusion, Leiden University Medical Center, Leiden, The Netherlands.; Bovens A; Division of Tumor Biology and Immunology, The Netherlands Cancer Institute-Antoni van Leeuwenhoek, 1066 CX, Amsterdam, The Netherlands.; Wessels L; Division of Molecular Carcinogenesis, Oncode Institute, The Netherlands Cancer Institute-Antoni van Leeuwenhoek, 1066 CX, Amsterdam, The Netherlands.; van Leeuwen F; Division of Gene Regulation, The Netherlands Cancer Institute-Antoni van Leeuwenhoek, 1066 CX, Amsterdam, The Netherlands.; Borst J; Division of Tumor Biology and Immunology, The Netherlands Cancer Institute-Antoni van Leeuwenhoek, 1066 CX, Amsterdam, The Netherlands. j.g.borst@lumc.nl.; Department of Immunohematology and Blood Transfusion, Leiden University Medical Center, Leiden, The Netherlands. j.g.borst@lumc.nl.

Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101528555 Publication Model: Electronic Cited Medium: Internet ISSN: 2041-1723 (Electronic) Linking ISSN: 20411723 NLM ISO Abbreviation: Nat Commun Subsets: MEDLINE

Severson TM; Zhu Y; Prekovic S; Schuurman K; Nguyen HM; Brown LG; Hakkola S; Kim Y; Kneppers J; Linder S; Stelloo S; Lieftink C; van der Heijden M; Nykter M; van der Noort V; Sanders J; Morris B; Jenster G; van Leenders GJ; Pomerantz M; Freedman ML; Beijersbergen RL; Urbanucci A; Wessels L; Corey E; Zwart W; Bergman AM

Country of Publication: United States NLM ID: 101767986 Publication Model: Electronic Cited Medium: Internet NLM ISO Abbreviation: medRxiv Subsets: PubMed not MEDLINE

Linder S; Division of Oncogenomics, Oncode Institute, The Netherlands Cancer Institute, Amsterdam, the Netherlands.; Hoogstraat M; Division of Oncogenomics, Oncode Institute, The Netherlands Cancer Institute, Amsterdam, the Netherlands.; Division of Molecular Carcinogenesis, Oncode Institute, The Netherlands Cancer Institute, Amsterdam, the Netherlands.; Stelloo S; Division of Oncogenomics, Oncode Institute, The Netherlands Cancer Institute, Amsterdam, the Netherlands.; Eickhoff N; Division of Oncogenomics, Oncode Institute, The Netherlands Cancer Institute, Amsterdam, the Netherlands.; Schuurman K; Division of Oncogenomics, Oncode Institute, The Netherlands Cancer Institute, Amsterdam, the Netherlands.; de Barros H; Division of Urology, The Netherlands Cancer Institute, Amsterdam, the Netherlands.; Alkemade M; Core Facility Molecular Pathology and Biobanking, The Netherlands Cancer Institute, Amsterdam, the Netherlands.; Bekers EM; Division of Pathology, The Netherlands Cancer Institute, Amsterdam, the Netherlands.; Severson TM; Division of Oncogenomics, Oncode Institute, The Netherlands Cancer Institute, Amsterdam, the Netherlands.; Division of Molecular Carcinogenesis, Oncode Institute, The Netherlands Cancer Institute, Amsterdam, the Netherlands.; Sanders J; Division of Pathology, The Netherlands Cancer Institute, Amsterdam, the Netherlands.; Huang CF; Vancouver Prostate Centre, University of British Columbia, Vancouver, British Columbia, Canada.; Morova T; Vancouver Prostate Centre, University of British Columbia, Vancouver, British Columbia, Canada.; Altintas UB; School of Medicine, Koç University, Istanbul, Turkey.; Koç University Research Centre for Translational Medicine (KUTTAM), Koç University, Istanbul, Turkey.; Hoekman L; Proteomics Facility, The Netherlands Cancer Institute, Amsterdam, the Netherlands.; Kim Y; Department of Pathology, Amsterdam University Medical Centers, Cancer Center Amsterdam, Amsterdam, the Netherlands.; Baca SC; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts.; The Eli and Edythe L. Broad Institute, Cambridge, Massachusetts.; Sjöström M; Department of Radiation Oncology, University of California, San Francisco, San Francisco, California.; Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, California.; Zaalberg A; Division of Oncogenomics, Oncode Institute, The Netherlands Cancer Institute, Amsterdam, the Netherlands.; Hintzen DC; Division of Cell Biology, Oncode Institute, The Netherlands Cancer Institute, Amsterdam, the Netherlands.; de Jong J; Division of Pathology, The Netherlands Cancer Institute, Amsterdam, the Netherlands.; Kluin RJC; Genomics Core Facility, The Netherlands Cancer Institute, Amsterdam, the Netherlands.; de Rink I; Genomics Core Facility, The Netherlands Cancer Institute, Amsterdam, the Netherlands.; Giambartolomei C; Department of Pathology and Laboratory Medicine, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, California.; Department of Human Genetics, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, California.; Seo JH; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts.; Pasaniuc B; Department of Pathology and Laboratory Medicine, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, California.; Department of Human Genetics, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, California.; Altelaar M; Proteomics Facility, The Netherlands Cancer Institute, Amsterdam, the Netherlands.; Biomolecular Mass Spectrometry and Proteomics, Bijvoet Center for Biomolecular Research, Utrecht Institute for Pharmaceutical Sciences, Utrecht University and Netherlands Proteomics Centre, Utrecht, the Netherlands.; Medema RH; Division of Cell Biology, Oncode Institute, The Netherlands Cancer Institute, Amsterdam, the Netherlands.; Feng FY; Department of Radiation Oncology, University of California, San Francisco, San Francisco, California.; Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, California.; Division of Hematology and Oncology, Department of Medicine, University of California, San Francisco, San Francisco, California.; Department of Urology, University of California, San Francisco, San Francisco, California.; Zoubeidi A; Vancouver Prostate Centre, University of British Columbia, Vancouver, British Columbia, Canada.; Department of Urologic Sciences, University of British Columbia, Vancouver, British Columbia, Canada.; Freedman ML; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts.; The Eli and Edythe L. Broad Institute, Cambridge, Massachusetts.; Wessels LFA; Division of Molecular Carcinogenesis, Oncode Institute, The Netherlands Cancer Institute, Amsterdam, the Netherlands.; Faculty of EEMCS, Delft University of Technology, Delft, the Netherlands.; Butler LM; Freemasons Centre for Male Health and Wellbeing, Adelaide Medical School, University of Adelaide, Adelaide, South Australia, Australia.; South Australian Health and Medical Research Institute, Adelaide, South Australia, Australia.; Lack NA; Vancouver Prostate Centre, University of British Columbia, Vancouver, British Columbia, Canada.; School of Medicine, Koç University, Istanbul, Turkey.; Koç University Research Centre for Translational Medicine (KUTTAM), Koç University, Istanbul, Turkey.; van der Poel H; Division of Urology, The Netherlands Cancer Institute, Amsterdam, the Netherlands.; Department of Urology, Amsterdam University Medical Centers, Amsterdam, the Netherlands.; Bergman AM; Division of Oncogenomics, The Netherlands Cancer Institute, Amsterdam, the Netherlands.; Division of Medical Oncology, The Netherlands Cancer Institute, Amsterdam, the Netherlands.; Zwart W; Division of Oncogenomics, Oncode Institute, The Netherlands Cancer Institute, Amsterdam, the Netherlands.; Laboratory of Chemical Biology and Institute for Complex Molecular Systems, Department of Biomedical Engineering, Eindhoven University of Technology, Eindhoven, the Netherlands.

Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 101561693 Publication Model: Print Cited Medium: Internet ISSN: 2159-8290 (Electronic) Linking ISSN: 21598274 NLM ISO Abbreviation: Cancer Discov Subsets: MEDLINE